Pericarditis associated with cytarabine therapy for acute myelocytic leukemia: a case report
- 27 October 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Pharmacology
- Vol. 74 (2), 181-182
- https://doi.org/10.1007/s00228-017-2355-7
Abstract
The incidence of cytarabine-induced pericarditis is rare. So far, only a few cases have been reported worldwide.Keywords
This publication has 11 references indexed in Scilit:
- Transient effusive‐constrictive pericarditis due to chemotherapyClinical Cardiology, 1999
- Successful administration of cytarabine after a previous anaphylactic reactionAllergy, 1997
- Pericarditis induced by high-dose cytosine arabinoside chemotherapyAnnals of Hematology, 1997
- Cytarabine-induced pericarditis: A case report and review of the literature of the cardio-pulmonary complications of cytarabine therapyLeukemia Research, 1995
- Pericarditis Associated with High-Dose Cytarabine Therapy for Acute Myeloblasts Leukemia: a Rare Complication of TherapyLeukemia & Lymphoma, 1992
- Pericarditis Induced by High-Dose Cytarabine TherapyArchives of Internal Medicine, 1984
- Cytarabine-Induced AnaphylaxisArchives of Internal Medicine, 1980
- Cytarabine-induced anaphylaxis. Demonstration of antibody and successful desensitizationArchives of Internal Medicine, 1980